Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine for cardiometabolic disease: a framework for clinical translation
Paul W. Franks, William T. Cefalu, John Dennis, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 822-835
Closed Access | Times Cited: 22

Showing 22 citing articles:

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Deirdre K. Tobias, Jordi Merino, Abrar Ahmad, et al.
Nature Medicine (2023) Vol. 29, Iss. 10, pp. 2438-2457
Open Access | Times Cited: 108
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 34
Personalized Intervention Based on Early Detection of Atherosclerosis
Rikke Vibeke Nielsen, Valentı́n Fuster, Henning Bundgaard, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 21, pp. 2112-2127
Closed Access | Times Cited: 20
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes
Richard David Leslie, Ronald C.W., Paul W. Franks, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 848-860
Open Access | Times Cited: 39
Unveiling diabetes onset: Optimized XGBoost with Bayesian optimization for enhanced prediction
Muhammad Khurshid, Sadaf Manzoor, Touseef Sadiq, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0310218-e0310218
Open Access | Times Cited: 1
The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries
Shivani Misra, Carlos A. Aguilar‐Salinas, Tinashe Chikowore, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 836-847
Closed Access | Times Cited: 13
The doctor and patient of tomorrow: exploring the intersection of artificial intelligence, preventive medicine, and ethical challenges in future healthcare
Paulo Santos, Isabel Nazaré
Frontiers in Digital Health (2025) Vol. 7
Open Access
Precision nutrition for cardiometabolic diseases
Marta Guasch‐Ferré, Clemens Wittenbecher, Marie Palmnäs-Bédard, et al.
Nature Medicine (2025)
Closed Access
Diabetes and obesity: leveraging heterogeneity for precision medicine
Paul W. Franks, Jennifer L Sargent
European Heart Journal (2024)
Open Access | Times Cited: 3
International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
Helena Teede, Matthew Gibson, Joop S.E. Laven, et al.
EClinicalMedicine (2024) Vol. 78, pp. 102927-102927
Closed Access | Times Cited: 3
Precision individualized medication strategies and challenges for cardiovascular diseases
Ting Yin, Jun Duan, Dong Xu, et al.
Precision medication. (2024) Vol. 1, Iss. 1, pp. 7-15
Open Access | Times Cited: 2
A Genetic Analysis of Current Medication Use in the UK Biobank
Palle Duun Rohde
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 319-319
Open Access | Times Cited: 1
Introduction: People, Place, Cancer
Trevor Dummer
Global perspectives on health geography (2024), pp. 3-15
Closed Access | Times Cited: 1
Cardiovascular autonomic dysfunction is linked with arterial stiffness across glucose metabolism: The Maastricht Study
Jonas R. Schaarup, Lasse Bjerg, Christian Stevns Hansen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
ZNAČAJ PRECIZNE MEDICINE I FARMAKOGENOMIKE U PREVENTIVNOJ PEDIJATRIJI
Ivana Kavečan, Nataša Nikolić, Đerđi Erdeš-Kavečan, et al.
Deleted Journal (2024), pp. 060-064
Open Access
Gene editing of angiotensin for blood pressure management
Stefano Masi, Hermann Dalpiaz, Claudio Borghi
International Journal of Cardiology Cardiovascular Risk and Prevention (2024) Vol. 23, pp. 200323-200323
Open Access
Advances in Personalized Medicine and Genomics for Diabetes Type-2 Management Towards Precision Health
Ayesha Javed, Madiha Tariq, Ghazanfar Hussain, et al.
Developmental medico-life-sciences (2024) Vol. 1, Iss. 6, pp. 36-44
Open Access
Targeting GPR39 in structure-based drug discovery reduces Ang II-induced hypertension
Dongxu Hua, Wanlin Huang, Qiyang Xie, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Effects of Baccharis dracunculifolia DC on an Innovative Animal Model of Cardiometabolic Syndrome
Gustavo Ratti da Silva, Arianne Jung Kluck, Edilson Rodrigues Albuquerque, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1446-1446
Open Access
Chrononutrition behaviors and cardiometabolic risk in adolescence: an ecological momentary assessment study
Yuting Shen, Qi Li, Yu-xiang Xu, et al.
European Journal of Nutrition (2024) Vol. 64, Iss. 1
Closed Access
Exploring the acceptability of a risk prediction tool for cardiometabolic risk (gestational diabetes and hypertensive disorders of pregnancy) for use in early pregnancy: a qualitative study
Sarah Lang, Jennifer J. McIntosh, Joanne Enticott, et al.
Midwifery (2024) Vol. 141, pp. 104270-104270
Closed Access
Risk factors for metabolic syndrome in the premetabolic state assessed using hierarchical clustering study in a health screening group
Sun-chul Park, Yu Na Kim, Byeong Kil Oh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top